133 related articles for article (PubMed ID: 24036631)
1. Genetic background modifies the effects of type 2 cannabinoid receptor deficiency on bone mass and bone turnover.
Sophocleous A; Idris AI; Ralston SH
Calcif Tissue Int; 2014 Mar; 94(3):259-68. PubMed ID: 24036631
[TBL] [Abstract][Full Text] [Related]
2. Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition.
Sophocleous A; Marino S; Kabir D; Ralston SH; Idris AI
Aging Cell; 2017 Oct; 16(5):1051-1061. PubMed ID: 28752643
[TBL] [Abstract][Full Text] [Related]
3. Modulation of strain-specific differences in gene expression by cannabinoid type 2 receptor deficiency.
Sophocleous A; Sims AH; Idris AI; Ralston SH
Calcif Tissue Int; 2014 Apr; 94(4):423-32. PubMed ID: 24370613
[TBL] [Abstract][Full Text] [Related]
4. Impaired border zone formation and adverse remodeling after reperfused myocardial infarction in cannabinoid CB2 receptor deficient mice.
Duerr GD; Heinemann JC; Gestrich C; Heuft T; Klaas T; Keppel K; Roell W; Klein A; Zimmer A; Velten M; Kilic A; Bindila L; Lutz B; Dewald O
Life Sci; 2015 Oct; 138():8-17. PubMed ID: 25447445
[TBL] [Abstract][Full Text] [Related]
5. Low-bone-mass phenotype of deficient mice for the cluster of differentiation 36 (CD36).
Kevorkova O; Martineau C; Martin-Falstrault L; Sanchez-Dardon J; Brissette L; Moreau R
PLoS One; 2013; 8(10):e77701. PubMed ID: 24204923
[TBL] [Abstract][Full Text] [Related]
6. Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons.
Canseco-Alba A; Schanz N; Sanabria B; Zhao J; Lin Z; Liu QR; Onaivi ES
Behav Brain Res; 2019 Mar; 360():286-297. PubMed ID: 30508607
[TBL] [Abstract][Full Text] [Related]
7. The cannabinoid receptor type 2 (CNR2) gene is associated with hand bone strength phenotypes in an ethnically homogeneous family sample.
Karsak M; Malkin I; Toliat MR; Kubisch C; Nürnberg P; Zimmer A; Livshits G
Hum Genet; 2009 Nov; 126(5):629-36. PubMed ID: 19565271
[TBL] [Abstract][Full Text] [Related]
8. Peripheral cannabinoid receptor, CB2, regulates bone mass.
Ofek O; Karsak M; Leclerc N; Fogel M; Frenkel B; Wright K; Tam J; Attar-Namdar M; Kram V; Shohami E; Mechoulam R; Zimmer A; Bab I
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):696-701. PubMed ID: 16407142
[TBL] [Abstract][Full Text] [Related]
9. Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice.
Li M; Healy DR; Li Y; Simmons HA; Crawford DT; Ke HZ; Pan LC; Brown TA; Thompson DD
Bone; 2005 Jul; 37(1):46-54. PubMed ID: 15869929
[TBL] [Abstract][Full Text] [Related]
10. The type 2 cannabinoid receptor regulates susceptibility to osteoarthritis in mice.
Sophocleous A; Börjesson AE; Salter DM; Ralston SH
Osteoarthritis Cartilage; 2015 Sep; 23(9):1586-94. PubMed ID: 25937028
[TBL] [Abstract][Full Text] [Related]
11. Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor.
Idris AI; Sophocleous A; Landao-Bassonga E; van't Hof RJ; Ralston SH
Endocrinology; 2008 Nov; 149(11):5619-26. PubMed ID: 18635663
[TBL] [Abstract][Full Text] [Related]
12. Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice.
Shapiro L; Wong JC; Escayg A
Epilepsia; 2019 Dec; 60(12):2359-2369. PubMed ID: 31758544
[TBL] [Abstract][Full Text] [Related]
13. Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral type 2 cannabinoid receptor.
Marino S; Idris AI
Pharmacol Res; 2017 May; 119():391-403. PubMed ID: 28274851
[TBL] [Abstract][Full Text] [Related]
14. Skeletal changes in transgenic male mice expressing human cytochrome p450 aromatase.
Peng Z; Li X; Mäkelä S; Väänänen HK; Poutanen M
J Bone Miner Res; 2004 Aug; 19(8):1320-8. PubMed ID: 15231020
[TBL] [Abstract][Full Text] [Related]
15. Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis.
Sisay S; Pryce G; Jackson SJ; Tanner C; Ross RA; Michael GJ; Selwood DL; Giovannoni G; Baker D
PLoS One; 2013; 8(10):e76907. PubMed ID: 24130809
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid Receptor 2 Modulates Maturation of Dendritic Cells and Their Capacity to Induce Hapten-Induced Contact Hypersensitivity.
Gaffal E; Kemter AM; Scheu S; Leite Dantas R; Vogt J; Baune B; Tüting T; Zimmer A; Alferink J
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31940843
[TBL] [Abstract][Full Text] [Related]
17. Prolyl Hydroxylase Domain-Containing Protein 3 Gene Expression in Chondrocytes Is Not Essential for Bone Development in Mice.
Xing W; Pourteymoor S; Gomez GA; Chen Y; Mohan S
Cells; 2021 Aug; 10(9):. PubMed ID: 34571849
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid CB2 receptors and hypersensitivity to methamphetamine: Vulnerability to schizophrenia.
Canseco-Alba A; Tabata K; Momoki Y; Tabassum T; Horiuchi Y; Arinami T; Onaivi ES; Ishiguro H
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Mar; 130():110924. PubMed ID: 38135096
[TBL] [Abstract][Full Text] [Related]
19. CB2-deficiency is associated with a stronger hypertrophy and remodeling of the right ventricle in a murine model of left pulmonary artery occlusion.
Duerr GD; Feißt A; Halbach K; Verfuerth L; Gestrich C; Wenzel D; Zimmer A; Breuer J; Dewald O
Life Sci; 2018 Dec; 215():96-105. PubMed ID: 30403990
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptors and the regulation of bone mass.
Bab I; Zimmer A
Br J Pharmacol; 2008 Jan; 153(2):182-8. PubMed ID: 18071301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
